IL6 and metabolic dysfunction-associated steatotic liver disease: Levels of intrahepatic IL-6, a major proinflammatory cytokine, are increased in patients with MASLD, and sustained upregulation of IL-6 in rodent models is able to perpetuate hepatic insulin resistance.61, 62